George Demetri

14PUBLICATIONS
110CO-AUTHORS
Molecular targetsLiquid biopsiesHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 26, 2026
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study.

Mrinal Gounder, Patrick Schöffski, Robin L Jones

|Jan 21, 2026
Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity.

Erica M Pimenta, Amanda E Garza, Sabrina Y Camp

|Jan 02, 2026
A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.

Gregory M Cote, Mason Aberoumand, Edwin Choy

|Jul 22, 2024
Improving Collection and Analysis of Overall Survival Data.

Lisa R Rodriguez, Nicole J Gormley, Ruixiao Lu

|May 09, 2024
Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma.

Gregory M Cote, Candace L Haddox, Edwin Choy

|Mar 24, 2022
Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression.

Matthew L Hemming, Patrick Bhola, Michael A Loycano

Pageof 3

Frequent Collaborators

4 joint publications

Matthew L Hemming

3 joint publications

Chandrajit P Raut

3 joint publications

Sandro Santagata

2 joint publications

Alexander Drilon